Inclusion-body myositis presenting with facial diplegia

Muscle and Nerve

Volumn 49, Issue 2, 2014, Pages 287-289

  Ghosh, Partha S ^a   Laughlin, Ruple S ^a   Engel, Andrew G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adult; Facial weakness; Facioscapulohumeral muscular dystrophy; Inclusion body myositis; Myopathy

Indexed keywords

CREATINE KINASE;

ABDUCTION; ADULT; ARTICLE; BICEPS BRACHII MUSCLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; ELECTROMYOGRAPHY; EXTENSOR MUSCLE; FACE MUSCLE; FACIAL NERVE PARALYSIS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HIP; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; LABORATORY TEST; MALE; MIDDLE AGED; MOTOR UNIT POTENTIAL; MUSCLE BIOPSY; MUSCLE WEAKNESS; PRIORITY JOURNAL; SHOULDER;

ADULT; FACIAL WEAKNESS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; INCLUSION-BODY MYOSITIS; MYOPATHY;

BIOPSY; COMORBIDITY; ELECTROMYOGRAPHY; FACIAL MUSCLES; HIP JOINT; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; SHOULDER JOINT;

EID: 84892506913     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24060     Document Type: Article

References (14)

1. Griggs RC, Askansas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713.
2. Benveniste O, Guiguet M, Freebody J. Long-term observational study of sporadic inclusion body myositis. Brain 2011;134:3176-3184.
3. Hohlfeld R. Update on inclusion body myositis. Brain 2011;134:3141-3145.
4. Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, et al. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 1996;40:581-586.
5. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: observation in 40 patients. Brain 1989;112:727-747.
6. Statland JM, Tawil R. Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions. Curr Opin Neurol 2011;24:423-428.
7. Figarella-Branger D, Pellissier JF, Serratrice G, Pouget J, Bianco N. Immunocytochemical study of the inflammatory forms of facioscapulohumeral myopathies and correlation with other types of myositis. Ann Pathol 1989;9:100-108.
8. Molnar M, Dioszeghy P, Mechler F. Inflammatory changes in facioscapulohumeral muscular dystrophy. Eur Arch Psychiatry Clin Neurosci 1991;241:105-108.
9. Arahata K, Ishihara T, Fukunaga H, Orimo S, Lee JH, Goto K, et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 1995;2(suppl):S56-66.
10. Amato AA, Barohn RJ. Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry 2009;80:1186-1193.
11. Dalakas MC. Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437-447.
12. Verma A, Bradley WG, Adesina AM, Sofferman R, Pendlebury WW. Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia. Muscle Nerve 1991;14:470-473.
13. Chahin N, Engel AG. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008;70:418-424.
14. Hilton-Jones D, Miller A, Parton M, Holton J, Sewry C, Hanna MG. Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. Neuromuscul Disord 2010;20:142-147.